Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Open-label, randomized, multicenter, international, parallel exploratory phase II study, comparing 3 FEC-3 Docetaxel chemotherapy to letrozole + palbociclib combination as neoadjuvant treatment of stage II-IIIA PAM 50 defined Luminal breast cancer, in postmenopausal women https://kusajili.com:443/Trial/mznC9M1fNki4FxFcRY9pgA%24open-label-randomized-multicenter-international-parallel-exploratory-phase-ii-study-comparing-3-fec-3-docetaxel-chemotherapy-to
I have read and accept the terms of use of the site and the Privacy Policy
Send your message